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TheroleofNFkBactivationandits relationshipto in¯ammatorymediatorsand
apoptosis in the HIV-infected brain have remained uncertain. The cellular and
regional distribution of NFkB, TNF-a, and apoptosis was examined in the
frontal cortex (FC), deep white matter (DWM) and the basal ganglia (BG) of 17
patients with ADC. Nuclear staining for NFkB was localized predominantly to
perivascular microglia/macrophages in the BG and DWM and correlated with
ADCseverity.CorrelationswerefurtherfoundwithHLA-DR,iNOS,TNF-a,and
gp41 expression in these regions. The number of TUNEL-positive cells,
particularly in the BG, correlated with ADC stage. Logistic regression analysis
further showed a signi®cant relationship between the likelihood of TUNEL
staining in the BG and worsening cognitive impairment. Journal of Neuro-
Virology (2000) 6, 537±543.
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It is now widely believed that HIV-induced brain
injury and AIDS-Dementia-Complex (ADC) are
related to indirect mechanisms mediated either by
HIV proteins including gp120, Tat, and gp41 and/or
host factors such as TNF-a, iNOS and the alpha
chemokine SDF-1a (Lipton and Gendelman, 1995;
Magnusen et al, 1995; Talley et al, 1995; Adamson
et al, 1996; Kaul and Lipton, 1999). These factors
have been shown in vitro to induce or amplify
cellular injury and apoptosis. Further, cytokines,
particularly TNF-a, and chemokines may act to
mediate or potentiate the neurotoxic effects of Tat
and gp120 (Yeung et al, 1995; Shi et al, 1998; New
et al, 1998). Additional support for the role of these
factors has come from in vitro studies that have
correlated immune activation as well as elevated
levels of TNF-a and iNOS mRNA in the deep white
matter with the degree of dementia (Wesselingh et
al, 1993; Adamson et al, 1996).
In concert with the in vitro ®ndings, neuronal loss
and apoptosis have been reported in brains of
subjects with ADC as well as in asymptomatic
individuals and are believed to comprise an
important component of the pathogenetic process
leading to this disorder (Wiley et al, 1991; Masliah
et al, 1992; Everall et al, 1993; Petito and Roberts
1995; Shi et al, 1996; An et al, 1996). Nonetheless,
the relationship of these ®ndings to dementia and
the underlying pathogenetic mechanisms have
remained uncertain.
Nuclear factor-kB( N F kB)/Rel proteins comprise
a family of host transcription factors that have
become recognized as central mediators of rapid
and coordinated induction of host and viral genes
in response to various stimuli including cytokines,
oxidative stress, viral products, glutamate and
beta-amyloid (Baeuerle and Henkel, 1994; Grilli
and Memo, 1999; Guerrini et al, 1995; Kaltschmidt
et al, 1999; Rattner et al, 1993). NFkBa c t i v a t i o n
has also been recently implicated in the pathogen-
esis of several neurodegenerative and in¯amma-
tory disorders, including Parkinson's Disease,
Alzheimer's Disease and multiple sclerosis (Hunot
et al, 1997; Kaltschmidt et al, 1997; Gveric et al,
1998).
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tion status of NFkBi nt h eH I V - i n f e c t e db r a i na n d
the role of apoptosis in relationship to ADC
severity, we studied 17 patients with AIDS at
various stages of cognitive impairment and without
a clinical history of a focal CNS process. The
neurological status was determined in 13 cases
within 1±2 weeks of death and by retrospective
chart review in the remaining four cases. The
diagnosis for ADC was based on American Acad-
emy of Neurology criteria (AAN AIDS Task Force,
1991) and severity was scored using the Memorial
Sloan Kettering scale as described by Price and
Brew (Price and Brew, 1988). ADC staging was as
follows: stage 0: four subjects; stage 1: ®ve subjects,
stage 2: three subjects; stage 3/4: ®ve subjects. The
severity of the HIV-encephalitis was graded based
on a modi®ed scale by Brew et al and scored
independently of gp41 as previously described
(Brew et al, 1995; Rostasy et al, 1999).
Paraf®n blocks of the frontal lobe with adjacent
deep white matter and basal ganglia including the
globus pallidus were obtained from 15 patients and
from frontal region only in two patients. The
samples were provided by the following institu-
tions: the New England Medical Center (9), Boston
City Hospital (4) and the Western General Hospital/
Edinburgh (Scotland) (4). All cases were coded as
previously described (Rostasy et al, 1999). Patholo-
gical examination did not reveal focal opportunistic
infections in any of these cases. Moderate to severe
HIVE with perivascular and less often parenchymal
multinucleated giant cells (MNGC) in the white
matter and/or basal ganglia was found in seven of 17
of the ADC subjects, six of whom were ADC stage
2±4. The remaining cases showed occasional
perivascular MNGC collections (n=3) or no brain
pathology (n=7).
Serial 7-mm sections were cut from paraf®n-
embedded blocks, were ¯oated onto warm water
without gelatin and mounted onto precleaned
Superfrost/Plus slides (Fisher Scienti®c). Hidden
antigen activity was reactivated as previously
described (Hedreen and Mucci, 1995; Rostasy et
al, 1999). The following commercially available
antibodies were used: TNF-a (1:1000, Sigma),
NFkB p65 (1:500, Santa Cruz Biotechnology).
Immunohistochemical staining was carried out
using the ABC method (Rostasy et al, 1999).
Negative controls included use of sections from
two HIV seronegative individuals without evidence
of brain pathology. The primary antibody was also
omitted on corresponding sections from the HIV
cases. One case showed positive staining for all the
above mentioned antigens tested and served as a
positive control.
Apoptosis was determined by the TdT-mediated
in situ DNA nick end labeling method (TUNEL)
(Migheli et al, 1994). Serial sections of two HIV
seronegative individuals without evidence of brain
pathology were used as negative controls. Four
cases with Alzheimer's disease were used as
positive controls. In addition, serial and adjacent
sections from 10 of 17 cases were incubated with
D N a s eIa n du s e da sa ni n t e r n a lc o n t r o lf o rT U N E L
positive cells.
The amount of staining was quanti®ed by two
independent observers (KR and BN), who were
blinded to the ADC or HIVE scores. The number of
TNF-a,N F kB and TUNEL positive stained cells was
determined by analyzing two serial sections from
the frontal lobe and basal ganglia in 15 and the
frontal cortex in 17 cases. The entire section was
scanned for positive staining cells. The degree of
staining was scored as follows: 0=no or only
nonspeci®c staining; 1 (rare)=1±5 positive cells; 2
(mild)=5±10; 3=10±20 (moderate); 4 (severe)=
greater than 20 or too numerous to count (Rostasy
et al, 1999).
The severity of ADC and HIVE was graded in a
four-step scale and the measure of association
between the two determined by the Spearman
correlation coef®cient. The abundance of immuno-
histochemical staining was compared with ADC
and HIVE scores (univariate analysis) using non-
parametric methods (Spearman rank order correla-
tion and Wilcoxon rank sum test). The abundance of
staining was also compared between the basal
ganglia and frontal lobe, adjusting for ADC stage
(multivariate analysis) by logistic regression analy-
sis.
In the HIV-infected subjects, intranuclear stain-
ing for NFkB using the p65/rel antibody was
predominantly found in perivascular microglia/
macrophages in the basal ganglia and frontal white
matter as opposed to the cortex, particularly in
subjects with severe dementia (Figure 1). As
previously described, TNF-a staining was localized
to the cytoplasmic area of perivascular microglia/
macrophages in a similar distribution (Wesselingh
Figure 1 Intranuclear NFkBp65 staining of microglia/macro-
phages in the basal ganglia in a patient with severe ADC (6400).
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Journal of NeuroVirologyet al, 1997). There was no difference in the
abundance of NFkBo rT N F - a staining between the
frontal white matter and the basal ganglia. Further,
NFkB activation generally correlated with the
abundance of TNF-a staining in the basal ganglia
and the deep white matter (P=0.012 and 0.028
respectively). In seven out of 17 cases (ADC stage
0±2 cases; stage 2±2, stage 3/4±3) and one
negative control brain, nuclear and cytoplasmic
staining of NFkB was detected in neurons and
astrocytes in both the frontal cortex and the basal
ganglia (data not shown). The number of these
positively stained cells was independent of the
degree of pathology or dementia score, consistent
with previous reports of constitutive NFkBe x p r e s -
sion in neuronal and glial cells (Kaltschmidt et al,
1994; Dollard et al, 1995).
To further assess the relationship between
NFkB activation and ADC, the degree of staining
was scored in both the frontal white matter and
basal ganglia and compared to the ADC stage. For
both NFkB and TNF-a, the degree of staining in
the frontal deep white matter and the basal
ganglia correlated with the stage of ADC (TNF-a:
P=0.0001 and P=0.0017 respectively; NFkB:
P=0.011 and P=0.014, respectively). The abun-
dance of NFkB activation in the frontal white
matter showed a statistical trend with the severity
of HIVE (P=0.08).
As NFkB exerts a central role in regulating the
expression of a number of proin¯ammatory and
viral genes, we tested the hypothesis that its
activation would correlate with the abundance of
HIV infection and in¯ammatory mediators pre-
viously associated with ADC. We compared the
extent of cellular expression of NFkB activation
with that of gp41, iNOS and microglial activation as
measured by HLA-DR staining (Rostasy et al, 1999).
In both the basal ganglia and the frontal deep white
matter, NFkB activation correlated strongly with the
abundance of HLA-DR staining (Table 1). Addition-
ally, NFkB activation correlated with the degree of
iNOS expression in both brain regions and gp41 in
the basal ganglia while a trend was noted in the
white matter (Table 1). The expression of TNF-a
also signi®cantly correlated with the abundance of
gp41 in the basal ganglia (P50.01), and a trend was
noted in the frontal white matter (P50.02) (data not
shown). Similar associations were observed be-
tween TNF-a a n di N O Si nt h e s er e g i o n s( P50.04
for the frontal white matter and P=0.07 in the basal
ganglia), further supporting the pathogenetic rela-
tionships that have been described in vitro between
these factors.
To further understand the relationship of apop-
tosis in the HIV-infected brain to ADC, we
compared the degree of TUNEL positive cells in
both the basal ganglia and the frontal lobe to ADC
stage and examined its relationship to the abun-
dance of staining for the proin¯ammatory mediators
described above. Apoptotic cells, including neu-
rons, were found in ®ve of eight cases with ADC
stages 2±4, predominantly in the basal ganglia (see
Figure 2) compared to two of nine subjects with
ADC stages 0±1. Apoptosis in the basal ganglia
correlated signi®cantly with the ADC stage
(P=0.021) and nearly reached statistical signi®cance
in the frontal cortex (P=0.052). This relationship
was further supported by logistic regression analy-
sis which showed a signi®cant relationship between
the likelihood of TUNEL staining in the basal
ganglia and worsening ADC (Figure 3). Probability
of staining increased from nearly 10% in subjects in
A D Cs t a g e0a n d0 . 5t og r e a t e rt h a n8 0 %i nt h o s e
with advanced dementia (ADC stage 3/4) while a
less pronounced effect was observed in the frontal
lobe.
No correlations were found between any of the
factors examined and apoptosis. Further, two cases
with ADC stage 1 and minimal pathology showed
numerous apoptotic cells in the basal ganglia but
were found to have minimal staining for TNF-a and
NFkB. Four brains with Alzheimer's Disease were
also studied, showing various degrees of TUNEL
positive cells in the hippocampal/parietal region.
NFkB staining was found in neurons and astrocytes
Table 1 Spearman correlation coef®cients (P values) of NFkB
with various factors associated with brain injury.
Factor
Brain region gp41 HLA-DR TNF-a iNOS
Basal ganglia
Frontal white matter
0.73
(0.0021)
0.53
(0.0300)
0.84
(0.0001)
0.79
(0.0002)
0.67
(0.0127)
0.56
(0.0285)
0.64
(0.0110)
0.60
(0.0106)
Given the number of comparisons within each brain region
(four), P-values less than 0.0125 are considered statistically
signi®cant to an (overall) signi®cance level of 5%. P-values
between 0.0125 and 0.05 are considered `statistical trends'.
Figure 2 TUNEL positive cells including neurons in the basal
ganglia in the same patient as above (6400).
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described (Kaltschmidt et al, 1997) but interestingly
no TNF-a staining was detected in any of the four
subjects.
The results show that NFkBa c t i v a t i o ni sp r e -
dominantly localized to perivascular macrophages/
microglia in both the frontal white matter and basal
ganglia and the abundance of staining in these
regions correlates with the severity of dementia.
Correlations were also found with microglial
activation as well as iNOS, TNF-a and gp41
expression, consistent with the notion that the
status of NFkB activation may be critical in
modulating the activity of these factors and perhaps
the course of injury in the HIV infected brain. In
addition, the cellular and regional expression of
TNF-a coincided with that found for NFkBa n dw a s
highly correlated with the severity of ADC, con-
sistent with previous reports (Wesselingh et al,
1993). As might be predicted, associations were also
found with iNOS and gp41 staining in the basal
ganglia and/or the frontal white matter. To our
knowledge this is the ®rst in vivo study to examine
the regional expression between NFkBa c t i v a t i o n
and TNF-a in relationship to ADC severity and the
expression of other host and viral factors. Together,
these results lend further support to the pathoge-
n e t i cr o l eo fT N F - a and identi®es NFkBa sa n o t h e r
central factor in the disease process.
The correlations found between TNF-a,N F kB
and gp41 are in concert with the in vitro observa-
tions that TNF-a, regulates HIV replication via
activation of NFkB which binds to regulatory
sequences in the long terminal repeat (LTR; Duh et
al, 1989; Atwood et al, 1994). NFkB also regulates
the expression of TNF-a, in addition to other
proin¯ammatory molecules while TNF-a has been
s u g g e s t e dt or e g u l a t ei N O Se x p r e s s i o ni nt h eb r a i n
(Philippon et al, 1994; Bukrinsky et al, 1995).
Further studies have shown that NFkB activation
in response to TNF-a is mediated by reactive oxygen
intermediates. Tat, which induces TNF-a activity,
has been shown to downregulate the expression of
Mn superoxide dismutase, thereby shifting the cell
toward oxidative conditions that favor NFkBa c t i v a -
tion (Westendorp et al, 1995). Thus TNF-a,N F kB
and HIV form part of a complex autoregulatory
system that is signi®cantly linked to the neuro-
pathogenesis of HIV induced brain injury and the
progression of cognitive impairment.
Whether NFkB activation contributes to neuronal
injury or confers neuroprotection has remained a
matter of debate. In a recent study, Kaltschmidt et al
showed that increased NFkBa c t i v a t i o ni np r i m a r y
neuronal cell cultures induced with low doses of
beta-amyloid and TNF-a protected against neuronal
cell death, suggesting a neuroprotective role for this
factor (Kaltschmidt et al, 1999). In vitro genetic
studies through the use of dominant negative
mutants that inhibit NFkB activation have also
shown that NFkB may indeed provide a protective
effect against cellular injury (Liu et al, 1996; Kneissl
and Navia, unpublished observation). Further
studies are needed to determine if NFkBm a yh a v e
a similar function in response to HIV-induced
neuronal injury.
In contrast, NFkBa c t i v a t i o ni nb r a i n sw i t h
multiple sclerosis has been localized to microglia
and correlated with the course of clinical disease
(Gveric et al, 1998), consistent with the reported
observations here and those previously reported by
Dollard et al who examined NFkBa c t i v a t i o ni nt h e
brains of children with HIV (Dollard et al, 1995).
Similar to our ®ndings, constitutive activation was
also observed in a small percentage of neurons and
astrocytes that did not differ from controls (Kaltsch-
midt et al, 1994; Dollard et al, 1995). Thus, NFkB
activation in neurons is not a prominent feature in
ADC and unlikely contributes directly to neuronal
injury. These ®ndings are also consistent with the in
vitro observation that neuronal loss in response to
Tat or TNF-a likely involves NFkB independent
mechanisms (Talley et al, 1995; New et al, 1998),
but are in contrast to a recent study by Tyler and
colleagues who have shown that NFkB is a critical
mediator of apoptosis in response to retroviral
infection (Connolly et al, 2000). Together the results
suggest that the role of NFkB is likely to be indirect,
primarily functioning within microglia and macro-
phages to sustain the production of proin¯amma-
tory mediators and HIV replication within a
Figure 3 Probability of TUNEL staining in the basal ganglia
(solid line) and the frontal cortex (dotted line), adjusted for the
severity of acquired immunode®ciency syndrome dementia
complex (ADC). TUNEL staining was more abundant in the
basal ganglia and increased linearly with the severity of ADC
stage (TUNEL Cortex/ADC=0.0452 and TUNEL Basal Ganglia/
ADC P=0.021 respectively). The results shown in this ®gure
were derived by means of a multivariate logistic regression
analysis of the probability of TUNEL staining in the basal ganglia
versus the frontal cortex.
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540complex network of host and viral factors that can
either contribute directly or amplify pathways
leading to neuronal injury.
The relationship of apoptosis to the degree of
dementia has largely remained an unresolved issue
(Everall et al, 1993; Seilhean et al, 1993; Petito et al,
1995; An et al, 1996; Shi et al, 1996). Recently, Gray
and colleagues found no global correlation between
neuronal apoptosis, HIV dementia or the presence
of encephalitis but noted a greater abundance of
apoptotic neurons in the basal ganglia, particularly
in subjects with HIV-encephalitis (Adle-Biassette et
al, 1999). Our ®ndings extend these observations, as
apoptotic cells were predominantly found in the
basal ganglia and to a lesser extent in the frontal
cortex. Further, the number of apoptotic cells in the
basal ganglia signi®cantly correlated with ADC
severity. This relationship was further supported
by the results of a logistic regression model, which
showed a signi®cant relationship between the
likelihood of TUNEL staining in the basal ganglia
and worsening ADC. These ®ndings are of interest
as they further support the notion that the develop-
ment and progression of cognitive impairment are
related to pathogenic events in the subcortical
regions, particularly the basal ganglia (Navia et al,
1986; Rostasy et al, 1999).
Although both microglial activation and the
abundance of staining for iNOS and gp41 in the
basal ganglia were signi®cantly correlated with
ADC, no such relationship between these factors
and apoptosis was found. This result may re¯ect the
small number of ADC cases with apoptosis com-
pared to those that showed positive staining for
these antigens or suggest that factors other than
those examined here may be important in mediating
apoptosis in the HIV-infected brain. The latter
notion is further supported by the ®nding of
signi®cant apoptosis in the basal ganglia of two
subjects with mild cognitive impairment and yet
absent staining of TNF-a and NFkB. Recent studies
have shown that strain differences in HIV may be
partly responsible for variations in the degree of
neuronal loss or apoptosis and that the envelope
may be directly involved. In one study, T-tropic or
CXCR4 using viruses caused greater neuronal
apoptosis than M-tropic strains while in another
study, blood-derived variants induced greater
cytopathogenicity in primary brain cultures when
compared to brain isolates (Ohagen et al, 1999;
Zheng et al, 1999). These ®ndings suggest the
hypothesis that polymorphisms in the envelope
region may contain determinants that may directly
cause neuronal injury (Ohagen et al, 1999; Zheng et
al, 1999).
Signi®cant progress has been made in identifying
potential agents of injury in the HIV-infected brain.
Further studies are clearly needed to unravel the
viral-host interactions and the signaling pathways
that mediate their neuropathogenic effects. These
efforts should help identify new targets for ther-
apeutic intervention in what is rapidly becoming a
chronic disease in response to dramatic changes in
antiretroviral therapy (Ferrando et al, 1998; Palella
et al, 1998).
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